We are live on
!
Find out more
WC
Weil Company Portfolio holdings
AUM
$445M
1-Year Est. Return
14.95%
This Fund
S&P 500
This Quarter
Est. Return
+10.08%
1 Year Est. Return
+14.95%
3 Year Est. Return
+51.9%
5 Year Est. Return
+85.1%
10 Year Est. Return
–
AUM
$220M
AUM Growth
+$56.9M
(+35%)
Cap. Flow
+$42.8M
Cap. Flow
% of AUM
19.49%
Top 10 Holdings %
Top 10 Hldgs %
42.33%
Holding
149
New
27
Increased
49
Reduced
38
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$10.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.03M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3.31M |
| 4 |
BNY Mellon Concentrated International ETF
BKCI
|
+$2.5M |
| 5 |
ProShares Short S&P500
SH
|
+$2.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.88M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$1.51M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$1.25M |
| 4 |
Walt Disney
DIS
|
+$827K |
| 5 |
Stride
LRN
|
+$797K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.74% |
| 2 | Financials | 11.7% |
| 3 | Healthcare | 11.27% |
| 4 | Real Estate | 8.62% |
| 5 | Industrials | 7.13% |
Similar funds
RWM
NAMP
BI
MLIC
JDLA
AFA
SGCM
WCP
Weil Company's Q4 2022 Portfolio in Review
As of Q4 2022, Weil Company held 149 positions worth $220M, up 35% from $163M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Weil Company deployed $42.8M of net new capital in Q4 2022, opening 27 new positions and adding to 49 existing holdings. Its largest new stake was ProShares Short S&P500: 37,537 shares worth $2.41M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was CVS Health, an estimated $1.88M trimmed.
- Weil Company's largest Q4 2022 buy was ProShares Short S&P500: 37,537 shares worth $2.41M.
- Weil Company added most to iShares Core US Aggregate Bond ETF in Q4 2022, an estimated $10.6M increase.
- Weil Company's biggest Q4 2022 reduction was CVS Health, cutting an estimated $1.88M.
- Weil Company fully exited iShares MSCI South Korea ETF in Q4 2022, selling an estimated $1.51M.
- Weil Company's ten largest holdings make up 42% of its $220M portfolio in Q4 2022.
- Weil Company opened 27 new positions and closed 11 in Q4 2022.
- Weil Company's portfolio value rose 35% quarter-over-quarter to $220M.
Based on Weil Company's 13F filing for Q4 2022, filed 8 Feb 2023.